624 reports of this reaction
4.0% of all CRISABOROLE reports
#6 most reported adverse reaction
PRURITUS is the #6 most commonly reported adverse reaction for CRISABOROLE, manufactured by Pfizer Laboratories Div Pfizer Inc. There are 624 FDA adverse event reports linking CRISABOROLE to PRURITUS. This represents approximately 4.0% of all 15,699 adverse event reports for this drug.
Patients taking CRISABOROLE who experience pruritus should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
PRURITUS is moderately reported among CRISABOROLE users, representing a notable but not dominant share of adverse events.
In addition to pruritus, the following adverse reactions have been reported for CRISABOROLE:
The following drugs have also been linked to pruritus in FDA adverse event reports:
PRURITUS has been reported as an adverse event in 624 FDA reports for CRISABOROLE. This does not prove causation, but indicates an association observed in post-market surveillance data.
PRURITUS accounts for approximately 4.0% of all adverse event reports for CRISABOROLE, making it a notable side effect.
If you experience pruritus while taking CRISABOROLE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.